You are here: Home > Our people > Nicholas Jones


+44 20 7940 3600

Email Nicholas

Office: London

Nicholas Jones BPharm, PhD, MRPharmS, MRSC, CPA, EPA


Nicholas is a patent attorney in our Life Sciences & Chemistry group, and leads our Pharmaceutical sector group.

Nicholas handles work in the fields of medicinal chemistry and drug design, synthetic organic chemistry, formulation, new medical indications, radiopharmaceuticals, advanced drug delivery, biopharmaceuticals, biosensors, drug delivery devices, coatings, agrochemicals, and chemical processes for the mining industry.  He also advises on Supplementary Protection Certificates for medicinal products and plant protection products.

Nicholas works with a number of domestic and overseas clients. He has worked for many years with companies in the Takeda Pharmaceutical Group, both in Japan and in Europe. He is a regular visitor to Japan, where he also works with a number of other pharmaceutical and chemical clients, including Ono Pharmaceutical and companies in the Sumitomo Group.  Closer to home, he works with the Portuguese pharmaceutical company BIAL – Portela & Ca. SA and the Swedish biosensor manufacturer Attana AB.  In the US, he works with Mallinckrodt Pharmaceuticals and the radiopharmaceuticals producer Curium Pharma, as well as a number of companies in the Koch Industries Group.

Prior to entering the patents profession, he gained experience in pharmaceutical research and development, particularly formulation technology and analytical research, with companies in the Glaxo Group (now GSK).

Education & background

Nicholas is a qualified pharmacist with substantial expertise across all areas of pharmaceutical research and development. He has Bachelor of Pharmacy (First Class Honours) and PhD degrees from the University of Nottingham.  He was the recipient of numerous university and industry awards throughout his first degree, both for academic excellence and original research.  His PhD research was in the field of gene therapy.

Nicholas joined Withers & Rogers in 1999, qualified as a Chartered Patent Attorney and European Patent Attorney in 2003 and became a Partner in 2006. In March 2023, he was registered as a representative before the new Unified Patent Court, one of the first European patent attorneys to be entered on the list of UPC representatives.

On a personal note...

Nicholas enjoys music, classical and medieval literature, walking, wine, whisky and the Japanese language.